Home » Stocks » VAPO

Vapotherm, Inc. (VAPO)

Stock Price: $33.02 USD 1.38 (4.36%)
Updated Jan 22, 2021 4:00 PM EST - Market closed
After-hours: $33.54 +0.52 (1.58%) Jan 22, 7:20 PM
Market Cap 847.33M
Revenue (ttm) 97.84M
Net Income (ttm) -46.77M
Shares Out 25.58M
EPS (ttm) -2.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 22
Last Price $33.02
Previous Close $31.64
Change ($) 1.38
Change (%) 4.36%
Day's Open 31.22
Day's Range 31.00 - 33.17
Day's Volume 553,042
52-Week Range 7.79 - 53.80

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Business Wire - 1 week ago

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprie...

Business Wire - 2 weeks ago

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprie...

Business Wire - 1 month ago

EXETER, N.H.--(BUSINESS WIRE)---- $VAPO--Vapotherm, Inc. (NYSE:VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of it...

Business Wire - 1 month ago

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprie...

Seeking Alpha - 2 months ago

Vapotherm's Hi-VNI technology is more comfortable and safer than current technologies used to treat patients with respiratory distress. The company has seen meaningful sales increases over the...

Seeking Alpha - 2 months ago

Vapotherm, Inc. (VAPO) CEO Joe Army on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 2 months ago

Vapotherm (VAPO) delivered earnings and revenue surprises of 19.67% and 26.80%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Business Wire - 2 months ago

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprie...

Zacks Investment Research - 2 months ago

Vapotherm (VAPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Business Wire - 2 months ago

MENLO PARK, Calif.--(BUSINESS WIRE)--CIBC Innovation Banking is pleased to announce a US$52 million growth capital financing with Exeter-based Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm”), a gl...

Business Wire - 3 months ago

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprie...

Business Wire - 3 months ago

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprie...

Business Wire - 3 months ago

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO) (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of Vapotherm's ...

Zacks Investment Research - 3 months ago

Vapotherm (VAPO) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

Seeking Alpha - 4 months ago

Vapotherm - COVID-19 Comes To The Rescue

Seeking Alpha - 5 months ago

Vapotherm, Inc. (VAPO) CEO Joe Army on Q2 2020 Results - Earnings Call Transcript

Business Wire - 5 months ago

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc.

Zacks Investment Research - 5 months ago

Vapotherm (VAPO) delivered earnings and revenue surprises of 10.26% and 20.80%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Business Wire - 5 months ago

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc.

Zacks Investment Research - 5 months ago

Vapotherm (VAPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Business Wire - 6 months ago

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc.

The Motley Fool - 8 months ago

The company's products are getting exposure, thanks in part to the coronavirus pandemic.

The Motley Fool - 8 months ago

The company released its fiscal first-quarter results.

Zacks Investment Research - 8 months ago

Vapotherm (VAPO) delivered earnings and revenue surprises of -17.86% and 1.14%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 8 months ago

Does Vapotherm (VAPO) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research - 8 months ago

As of late, it has definitely been a great time to be an investor Vapotherm

Zacks Investment Research - 8 months ago

Oxygen therapy has emerged as a necessity for COVID-19 patients.

Other stocks mentioned: INGN, IVC
Zacks Investment Research - 9 months ago

Vapotherm (VAPO) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Seeking Alpha - 10 months ago

Vapotherm, Inc. (VAPO) CEO Joe Army on Q4 2019 Results - Earnings Call Transcript

Zacks Investment Research - 10 months ago

Vapotherm (VAPO) delivered earnings and revenue surprises of 16.67% and 6.64%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Seeking Alpha - 1 year ago

Vapotherm, Inc. (VAPO) CEO Joe Army on Q3 2019 Results - Earnings Call Transcript

GuruFocus - 1 year ago

President & CEO of Vapotherm Inc (30-Year Financial, Insider Trades) Joseph Army (insider trades) bought 10,000 shares of VAPO on 09/04/2019 at an average price of $10 a share.

Zacks Investment Research - 1 year ago

Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.

Other stocks mentioned: ACMR, CMCO, EQC, LRN
Seeking Alpha - 1 year ago

Vapotherm, Inc. (VAPO) CEO Joseph Army on Q2 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Vapotherm, Inc. (VAPO) CEO Joe Army on Q1 2019 Results - Earnings Call Transcript

About VAPO

Vapotherm, a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, incl... [Read more...]

Industry
Medical Devices
IPO Date
Nov 14, 2018
CEO
Joe Army
Employees
279
Stock Exchange
NYSE
Ticker Symbol
VAPO
Full Company Profile

Financial Performance

In 2019, Vapotherm's revenue was $48.10 million, an increase of 13.51% compared to the previous year's $42.38 million. Losses were -$51.06 million, 20.2% more than in 2018.

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for Vapotherm stock is "Strong Buy." The 12-month stock price forecast is 41.75, which is an increase of 26.44% from the latest price.

Price Target
$41.75
(26.44% upside)
Analyst Consensus: Strong Buy